Succinate supplementation improves metabolic performance of mixed glial cell cultures with mitochondrial dysfunction

Abstract Mitochondrial dysfunction, the inability to efficiently utilise metabolic fuels and oxygen, contributes to pathological changes following traumatic spinal cord or traumatic brain injury (TBI). In the present study, we tested the hypothesis that succinate supplementation can improve cellular...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Susan Giorgi-Coll, Ana I. Amaral, Peter J. A. Hutchinson, Mark R. Kotter, Keri L. H. Carpenter
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1e35d43f0d3549c7bfdec73a8e038567
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1e35d43f0d3549c7bfdec73a8e038567
record_format dspace
spelling oai:doaj.org-article:1e35d43f0d3549c7bfdec73a8e0385672021-12-02T15:18:52ZSuccinate supplementation improves metabolic performance of mixed glial cell cultures with mitochondrial dysfunction10.1038/s41598-017-01149-w2045-2322https://doaj.org/article/1e35d43f0d3549c7bfdec73a8e0385672017-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01149-whttps://doaj.org/toc/2045-2322Abstract Mitochondrial dysfunction, the inability to efficiently utilise metabolic fuels and oxygen, contributes to pathological changes following traumatic spinal cord or traumatic brain injury (TBI). In the present study, we tested the hypothesis that succinate supplementation can improve cellular energy state under metabolically stressed conditions in a robust, reductionist in vitro model of mitochondrial dysfunction in which primary mixed glial cultures (astrocytes, microglia and oligodendrocytes) were exposed to the mitochondrial complex I inhibitor rotenone. Cellular response was determined by measuring intracellular ATP, extracellular metabolites (glucose, lactate, pyruvate), and oxygen consumption rate (OCR). Rotenone produced no significant changes in glial ATP levels. However, it induced metabolic deficits as evidenced by lactate/pyruvate ratio (LPR) elevation (a clinically-established biomarker for poor outcome in TBI) and decrease in OCR. Succinate addition partially ameliorated these metabolic deficits. We conclude that succinate can improve glial oxidative metabolism, consistent our previous findings in TBI patients’ brains. The mixed glial cellular model may be useful in developing therapeutic strategies for conditions involving mitochondrial dysfunction, such as TBI.Susan Giorgi-CollAna I. AmaralPeter J. A. HutchinsonMark R. KotterKeri L. H. CarpenterNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-9 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Susan Giorgi-Coll
Ana I. Amaral
Peter J. A. Hutchinson
Mark R. Kotter
Keri L. H. Carpenter
Succinate supplementation improves metabolic performance of mixed glial cell cultures with mitochondrial dysfunction
description Abstract Mitochondrial dysfunction, the inability to efficiently utilise metabolic fuels and oxygen, contributes to pathological changes following traumatic spinal cord or traumatic brain injury (TBI). In the present study, we tested the hypothesis that succinate supplementation can improve cellular energy state under metabolically stressed conditions in a robust, reductionist in vitro model of mitochondrial dysfunction in which primary mixed glial cultures (astrocytes, microglia and oligodendrocytes) were exposed to the mitochondrial complex I inhibitor rotenone. Cellular response was determined by measuring intracellular ATP, extracellular metabolites (glucose, lactate, pyruvate), and oxygen consumption rate (OCR). Rotenone produced no significant changes in glial ATP levels. However, it induced metabolic deficits as evidenced by lactate/pyruvate ratio (LPR) elevation (a clinically-established biomarker for poor outcome in TBI) and decrease in OCR. Succinate addition partially ameliorated these metabolic deficits. We conclude that succinate can improve glial oxidative metabolism, consistent our previous findings in TBI patients’ brains. The mixed glial cellular model may be useful in developing therapeutic strategies for conditions involving mitochondrial dysfunction, such as TBI.
format article
author Susan Giorgi-Coll
Ana I. Amaral
Peter J. A. Hutchinson
Mark R. Kotter
Keri L. H. Carpenter
author_facet Susan Giorgi-Coll
Ana I. Amaral
Peter J. A. Hutchinson
Mark R. Kotter
Keri L. H. Carpenter
author_sort Susan Giorgi-Coll
title Succinate supplementation improves metabolic performance of mixed glial cell cultures with mitochondrial dysfunction
title_short Succinate supplementation improves metabolic performance of mixed glial cell cultures with mitochondrial dysfunction
title_full Succinate supplementation improves metabolic performance of mixed glial cell cultures with mitochondrial dysfunction
title_fullStr Succinate supplementation improves metabolic performance of mixed glial cell cultures with mitochondrial dysfunction
title_full_unstemmed Succinate supplementation improves metabolic performance of mixed glial cell cultures with mitochondrial dysfunction
title_sort succinate supplementation improves metabolic performance of mixed glial cell cultures with mitochondrial dysfunction
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/1e35d43f0d3549c7bfdec73a8e038567
work_keys_str_mv AT susangiorgicoll succinatesupplementationimprovesmetabolicperformanceofmixedglialcellcultureswithmitochondrialdysfunction
AT anaiamaral succinatesupplementationimprovesmetabolicperformanceofmixedglialcellcultureswithmitochondrialdysfunction
AT peterjahutchinson succinatesupplementationimprovesmetabolicperformanceofmixedglialcellcultureswithmitochondrialdysfunction
AT markrkotter succinatesupplementationimprovesmetabolicperformanceofmixedglialcellcultureswithmitochondrialdysfunction
AT kerilhcarpenter succinatesupplementationimprovesmetabolicperformanceofmixedglialcellcultureswithmitochondrialdysfunction
_version_ 1718387434399465472